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Abstract

Allopurinol alters the expression of cytokines and mediators of immune cells in the systemic
tissue by decreasing plasma urate.
Lundrim Marku
Diminished levels of urate have been linked to oxidative stress in birds and mammals.
Urate, a major antioxidant that lowers reactive oxygen/nitrogen species (ROS/RNS), is thought
to ameliorate the effects. The relationship between reduced urate, the immune system and the
pathogenesis of the intestine, the liver or the brain has not been well characterized in avians.
Moreover, recent studies have proposed that an increased permeability in the intestine due to
some insult can induce inflammation in peripheral organs such as the brain. Allopurinol, a
relatively toxic purine analogue that serves as a xanthine oxidase inhibitor, reduces urate levels
which can subsequently induce an inflammation state in the intestine. For this study, White
Leghorn Chickens (n=44) were divided into 11 groups, which constituted of six control groups
and five allopurinol treatments fed at 15 mg/kg body weight. The dose of allopurinol was
increased 5 mg/kg body weight each week for 12 weeks. Blood samples were obtained by from
the brachial vein of the wing. Liver panel blood chemistries were performed to characterize the
inflammations state. At the end of the study, tissues were removed after cervical dislocation and
placed in liquid nitrogen. Expression levels of TNF-α, IL-6, FASLG and COX-2 were
subsequently investigated in the intestines, liver and midbrain. The results showed that urate was
reduced in all treatment groups regardless of time (p < 0.05), treatment groups exhibited reduced
amounts of bile acids throughout time (p < 0.05) and female treatment groups exhibited
increased amounts of LDH and AST from week 2 to the end of the experiment (p < 0.05). The
effect of allopurinol on the intestines of females showed that expression of IL-6, COX-2, TNF-α
expression increased from every other group by 185.93, 211.74 and 107.52 times respectively (p
< 0.05). TNF-α expression in the liver decreased in both females and males by 3 and 2-fold
respectively (p < 0.05). FASLG expression in the liver decreased 2-fold in both male and
females respectively (p < 0.05). The effect of allopurinol on the midbrain of females showed that
IL-6 expression decreased by 0.061fold (?) (p < 0.05) whereas in males IL-6 expression
increased by almost 2-fold (p < 0.05). COX-2 expression in the midbrain increased in females
and males by 7 and 10 times (p < 0.05). The midbrain of treated females reveal that the
inflammatory potential was reduced in the brain tissue of female chickens due to decreased IL-6
expression. Females were found respond more intensely to allopurinol administration from an
increase of intestinal permeability which could alter the laying quality and reproductive fitness.
Lastly, an upregulation of IL-6 in males also induce inflammation and could be used to create a
model of neuropathological disorders.
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i.

Introduction

Urate is synthesized the liver, intestines and the vascular endothelium as a product of an
exogenous pool of purines [1]. Urate can also be produced endogenously by damaged, dying or
dead cells; where nucleic acids, adenine, and guanine, are degraded into urate to act as damageassociated molecular patterns [1], [2]. This biomolecule conventionally generates concerns due
to acute and chronic inflammatory arthritis, gout, and other metabolic diseases [1], [3]. However,
it is also thought to have a dual role and serve by inducing a type 2 immune response [1], [2],
[4]. The inhibition of urate production can elucidate the protective potential by observing how
lowered urate concentrations alter immunological function in several organs [5], [6]. Several
studies have indicated how the intestinal environment can exert profound effects on the liver and
central nervous system through the regulation of the microbiota and the intestinal barrier
function [7]. This gut-brain connection is becoming a model of immune activity with a
fundamental contribution towards neurodegenerative disorders [7]. These studies indicate that
inflammation in the intestine appears to be particularly relevant in the disease pathogenesis.
Studies have shown that urate serves as a potent scavenger of singlet oxygen, peroxyl
radicals and hydroxyl radicals [6]. Elevated urate concentrations in the circulation helps to
protect cells by scavenging these free radicals which then prolongs the organism’s life [6], [8].
Living systems have adapted to regulate free radicals by developing pathways to inactivate these
reactive species such as oxygen and nitrogen, which induce tissue injury [6], [9]. Allopurinol, a
toxic purine analog, serves as a xanthine oxidase inhibitor which reduces urate concentrations;
which can induce a type I inflammation state in the intestine and the brain of birds [3]. Changes
in the compositions of the bacterial populations in the intestines have also been widely associated
with an array of conditions that can cause neurological and developmental disorders such as

multiple sclerosis, autism, depression, schizophrenia, and Parkinson’s disease [4], [7].
Shifts in intestinal microbiota can alter levels of growth factors and signaling proteins in
the brain, which contributes to functional changes in the remodeling and inflammation?[5].
Among the roles for gut bacteria are the conversion of primary bile acids produced by the liver to
secondary bile acids which then are absorbed through the intestinal epithelium [7]. Moreover,
bile acids can also act as potent signaling molecules that regulate a variety of processes related to
both the nervous and immune systems. A detailed look into the effects of allopurinol on the early
recognition and effector response by the immune system in the intestines could elucidate how
these responses affect the liver and brain [4], [7]. Metabolites generated from intestinal microbes
such as those described here have also been reported to alter host gene expression in the brain,
providing ways for the microbiota to influence the activity of the CNS [4], [7]. Thus, the
administration of allopurinol can evoke strong type 1 immune reactions via IL-6 by altering the
intestinal environment and induce effects that ultimately alter CNS function.
The Immune System and The Urate Paradox
A vast amount literature shows an elevated level of urate is strongly associated with
inflammatory diseases such as hypertension, cardiovascular and cerebrovascular events [2], [3],
[10]. While urate does account for over half of the free radical scavenging activity in blood [8], it
can also be thought to combat the oxidative stress implicated in several neurodegenerative
diseases. Antioxidant activities of urate can quench superoxide and singlet oxygen and protecting
oxidation of vitamin C through the chelation of iron [6], [11]. These qualities make urate an
attractive CNS antioxidant because neurons are remarkably susceptible to oxidative stress. In
multiple sclerosis, free radicals can contribute to the inflammation and demyelination of axons
[10], [12]. Thus, preventing oxidative damage may delay onset and improve the prognosis of
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CNS disorders [10]. The ratio of reactive species over antioxidants determine the shift from their
advantageous function to detrimental effects [11]. The major source of these reactive species that
become detrimental are dependent on cell type, duration of oxidant production, reactive species
produced, and the localization of their source [6]. The oxidant-antioxidant paradox can be further
investigated by the analyzing how decreased blood urate can alter various genes associated with
inflammation [4], [6], [10].
Urate’s Systemic Effects
Immune cells can engage in direct communication with these dying cells as well as with
neurons. The extent of the functional impact of neuroimmune synapses is not known. However,
activated immune cells can modulate neuronal activity by using neurotransmitters and cytokines
[4]. Proinflammatory cytokines and activated immune cells in the circulation also access the
brain when the blood brain barrier is compromised [2]. Systemic inflammation associated with
increased BBB permeability can be considered a precursor to neurodegenerative diseases [13].
Extensive evidence has reported linking molecules associated with inflammatory conditions,
which include cytokines, reactive oxygen species, matrix metalloproteases, and mediators of
angiogenesis with blood brain barrier disruption [2], [13]. Additionally, a positive feedback loop
involving IL-6 in conjunction with neuroimmune reflex circuits has been implicated in
increasing permeability such that peripheral T cells gain access to the CNS [7]. Leaks in the
blood brain barrier can significantly alter immune responses to CNS antigens and compromise
CNS protection against potentially harmful substances [7], [13].
The systemic effects of intestinal inflammation may be further augmented by increases in
intestinal permeability via some insult to the gut [7]. Acute tissue injury may occur with a severe
infection generated by an intestinal pathogen, which causes temporary defects in the intestinal

epithelial barrier [2]. These low-grade insults induce more selective increases in paracellular
permeability through regulation of tight junctions. Intestinal microbes also regulate expression of
barrier promoting tight junction proteins [7]. While many proinflammatory cytokines secreted by
activated immune cells, which include TNF, IL-1β, and IL-6, allow for tight junctions to increase
barrier permeability in order to facilitate recruitment of immune cells and other molecules [2],
[14], [15], [16], [17], [18]. However, a side effect of this response permits microbes to leak from
the intestine into the peritoneal cavity and from there into the blood, which then triggers a
systemic proinflammatory immune responses [7].
Typically, the immune challenge is rapidly cleared, proinflammatory responses terminate,
and gut barrier function is restored [7]. However, unique features of the intestine allow for
persistent inflammation and barrier dysfunction [7]. Sustained permeability of the intestinal
barrier can have harmful effects on numerous body systems. Many microbial components can
trigger “leaky gut syndrome” and lead to conditions like Irritable bowel syndrome (IBS) and
metabolic syndrome. Moreover, recent studies have implicated that intestinal permeability can be
with linked with CNS dysfunction, which include Parkinson’s, Alzheimer’s, autism,
schizophrenia, multiple sclerosis, depression, anxiety, and post-traumatic stress disorder [7], [7].
Proinflammatory responses in the brain can alter CNS function and CNS immune responses can
have serious and enduring consequences. If inflammation becomes chronic, proinflammatory
cytokines and oxidative stress that are linked to neuron death, and neuroinflammation should be
investigated as a key factor in numerous neurodegenerative diseases.
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ii.

Materials and Methods

All procedures and experiments were approved by West Virginia University’s Institution
Animal Care and Use Committee 1708009034.
Experimental Design
Chickens were housed within pens and maintained under a twelve-hour light-dark cycle
with temperature set at 27°C. One dose of allopurinol will be administered (15 mg/kg of body
weight) as a feed additive to chickens. The chickens were allowed a growth period of two to
three weeks before the start of treatments. On the third week of age, the chickens will be
assigned at random into treatment groups, Control diet and Allopurinol in the diet. The
treatment period will be 12 weeks until euthanasia. Three weeks after growth, chickens (n = 44)
were divided into 11 groups and tagged with a leg band. The chickens were maintained on a
starter diet before the experiment began. The leghorn chickens were started on their respective
treatment’s allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Food and
water were provided ad libitum. At 12 weeks of age the birds were killed by cervical dislocation
and the intestines, liver and midbrain tissues were removed and stored in liquid nitrogen prior to
analysis.

Sampling procedure
Blood samples were obtained from the brachial wing vein of 2 birds per pen at week two
of treatment for twelve weeks. Each blood sample was placed in a heparinized tube and stored on
ice. The blood samples were centrifuged at 2000rpm for 20 minutes at 4°C. Plasma samples were
then transferred to micro-centrifuge tube and stored in a -80° C freezer pending analysis.

Sample analysis
Plasma uric acid (PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent
assay from Thermo Scientific (Waltham, MA, USA). Liver Blood panel chemistries were
performed with the help of Dr. Jesse Fallon at the Cheat Lake Veterinary Hospital.
RNA Extraction, cDNA Synthesis and qPCR Total RNA
The primers used in these experiments can be referred to Table 1. Total RNA was
isolated from tissues using the TRIZOL Reagent (Invitrogen, Carlsbad, CA). To quantify
expression levels, equal amounts of cDNA were synthesized using the Advantage RT-for-PCR
kit (Clontech, Mountain View, CA). GAPDH was amplified as an internal control. qPCR was
performed using Power SYBR Green PCR Master Mix (Applied Biosystems). All qPCR was
performed using SYBR Green, conducted at 50°C for 2 minutes, 95°C for 10 minutes, and then
40 cycles of 95°C for 15 seconds and 60°C for 1 minutes. The specificity of the reaction was
verified by melt curve analysis. qPCR was conducted at 95°C for 10 minutes, followed by 40
cycles of 95°C for 15 seconds and 60°C for 1 minutes. The threshold crossing value was noted
for each transcript and normalized to the internal control. The relative quantitation of each
mRNA was performed using the comparative delta delta Ct method. Experiments were
performed using an ABI Prism 7900 System (Applied Biosystems), and data processing was
performed using ABI SDS v2.1 software (Applied Biosystems).
Statistical Analysis
The statistical program SAS (version 14.3; SAS Institute Inc., Cary, NC) was used to
analyze the data. Both time and treatment effects were analyzed. Weeks were considered as a
fixed effect whereas birds were treated as random effect. A generalized linear model was used to
study the treatment effect at week 12 of the study. Values are expressed as least square (LSM) ±

7

standard error (SE) unless stated otherwise. JMP and SAS software (JMP®, Version Pro 14.0,
SAS Institute Inc., Cary, NC, Copyright ©2015; SAS®, Version 9.4, SAS Institute Inc., Cary,
NC, Copyright ©2002-2012). Significance criterion alpha for all tests was set to 0.05.
iii.

Results

Plasma Urate and Liver Panel
The results showed that plasma urate was reduced in all treatment groups regardless of
time (p < 0.05) (Figure 1K). Treatment groups exhibited reduced amounts of bile acids
throughout the study period (p < 0.05) (Figure 1L) while female treated birds exhibited increased
amounts of LDH and AST over time (p < 0.05) (Figure 1D and 1J).
Intestines
In female chicks, allopurinol increased IL-6, COX-2, TNF-α expression by 186, 212 and
108 times respectively (p < 0.05) (Figure 2A-C) with the combination of sex and treatment found
to be significant (p <0.05) (Figure 2A). Tukey HSD, teste done to determine if there is an honest
significant difference of LSM differences revealed that IL-6 expression was increased in females
that were fed the allopurinol treatment (p < 0.05).
Liver
The effect of allopurinol on TNF-α expression was decreased in both females and males
by 3 and 2-fold compared to their respective control groups (p < 0.05) (Figure 3a). The effect of
allopurinol on FASLG expression in the liver was decreased by 2 times in both male and females
from their respective control groups (p < 0.05) (Figure 3b).
Midbrain
Allopurinol administration to female chickens decreased IL-6 expression from its

respective control to a fold change of 0.061 (p < 0.05) (Figure 4a) with the combination of sex
and treatment also found to be significant (p < 0.05). Allopurinol administration to male chickens
increased IL-6 expression from the respective controls by 1.98 times (p < 0.05) (Figure 4a) with
the combination of sex and treatment was found to be significant (p < 0.05). Tukey HSD of LSM
differences revealed that females with the allopurinol treatment have statistically decreased from
every other group. Males were also found to statistically decrease from every other group with
the control groups of both sexes statistically similar to each other. Allopurinol increased COX-2
expression in the midbrain in both females and males by 7 and 10-fold compared to their
respective control groups (p < 0.05) (Figure 4b).
Figure 1A. Albumin-to-Globulin Ratio. Total plasma protein concentrations in female
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control
Males (n = 11) at 2, 6, 12 wks of age.
Figure 1B. Albumin Concentrations. Total albumin concentrations in g/dL. Female
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control
Males (n = 11) at 2, 6, 12 wks of age.
Figure 1C. Alkaline Phosphatase. Alkaline phosphatase concentrations in IU/L. Female
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control
Males (n = 11) at 2, 6, 12 wks of age.
Figure 1D. Aspartate Aminotransferase. Aspartate aminotransferase concentrations in
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IU/L. Female treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age;
Male treated chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of
age. Control Males (n = 11) at 2, 6, 12 wks of age. Female treated birds exhibited increased
amounts of AST over time (p < 0.05).
Figure 1E. Creatine Kinase. Creatine kinase concentrations in IU/L. Female treated
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males
(n = 11) at 2, 6, 12 wks of age.
Figure 1F. Globulin. Globulin concentrations in g/dL. Female treated chickens (n = 11)
female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12
wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12
wks of age.
Figure 1G. Phosphorus. Phosphorus concentrations in mg/dL. Female treated
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males
(n = 11) at 2, 6, 12 wks of age.
Figure 1H. Blood Urea Nitrogen. BUN. Female treated chickens (n = 11) female treated
chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12 wks of age;
Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12 wks of age.
Figure 1I. Total Protein. Total protein concentrations in g/dL. Female treated chickens
(n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at
2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2,

6, 12 wks of age.
Figure 1J. Lactate Dehydrogenase. LDH concentrations in IU/L. Female treated
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males
(n = 11) at 2, 6, 12 wks of age. Female treated birds exhibited increased amounts of LDH over
time (p < 0.05).
Figure 1K. Urate. Urate concentrations in mg/dL. Female treated chickens (n = 11)
female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12
wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12
wks of age. Plasma urate was reduced in all treatment groups regardless of time (p < 0.05).
Figure 1L. Bile Acids. Bile Acids concentrations in μmol/l. Female treated chickens
(n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at
2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2,
6, 12 wks of age. Treatment groups exhibited reduced amounts of bile acids throughout time (p <
0.05).
qPCR
Table 1. Oligonucleotide primers for qPCR

Gene

Forward (5'-3')

Reverse (5'-3')

Annealing (°C)

Accession
Number

*GAPDH

Ggtggccatcaatgatccct

Ccgttctcagccttgacagt

60

NC_006088.5

TNF-alpha

Gagatcctccctgcactgaa

Cacatcccctttctggaaga

60

NC_006101.5

FASLG

Tgctggacctcgtttagctt

Ctcatttcccactgccatct

60

NC_006093.5

IL-6

Aatggtgggggtcatatcaa

Agtcacgtttgatggcttcc

60

NC_006089.5

OCLN

Cgagttggatgagtcccagta

Ggtgtcgaactcctgcttgta

60

NC_006115.5

11

COX-2

Tcctcatgttcctgagcatct

Gctcctgtttcaagagctcac

60

NC_006095.5

KRT18

Gaactactgggacaccatcca

Atgcctcatacttcaccctga

60

NC_008465.4

CRP

Tcttctcctacgccaccaaa

Acgcggaaggtgacgtattt

60

NC_006112.4

Figure 2a. The effect of allopurinol on IL-6 expression in the intestines of allopurinol fed
chickens and healthy controls. IL6 mRNA was normalized to that of GAPDH. Female treated
chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males (n = 3).
The treated female group had an LSM=185.93 and SE=32.74. The F-ratio was 7.25 and the pvalue = 0.0376 using an ANOVA test. The combination of sex and treatment was found to be
significant with females at t-Ratio 2.72 and p-value=0.0263. Tukey HSD of LSM differences
show that females with the allopurinol treatment IL-6 expression are statistically different from
every group.
Figure 2b. The effect of allopurinol on COX-2 expression in the intestines of allopurinol fed
chickens and healthy controls. COX-2 mRNA was normalized to that of GAPDH. Female
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males
(n = 3). The treated female group had an LSM=211.74 and SE=18.144. The F-ratio was 11.909
and the p-value=0.0376 using an ANOVA test. The combination of sex and treatment was found
to be significant with females at t-Ratio 4.31 and p-value=0.0191.
Figure 2c. The effect of allopurinol on TNF-α expression in the intestines of allopurinol fed
chickens and healthy controls. TNF-α mRNA was normalized to that of GAPDH. Female
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males
(n = 3). The treated female group had an LSM=211.74 and SE=18.144. The F-ratio was 4.58 and
the p-value=0.0376 using an ANOVA test. The treatment was found to be significant at a t-Ratio

2.68 and p-value=0.0281.
Figure 3a. The effect of allopurinol on TNF-α expression in the liver of allopurinol fed
chickens and healthy controls. TNF-α mRNA was normalized to that of GAPDH. Female
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males
(n = 3). TNF-α expression of treated groups was statistically different from the control groups.
The F-ratio was 4.33 and the p-value=0.0432 using an ANOVA test. All groups were found to
similar when analyzing with Tukey-HSD.
Figure 3b. The effect of allopurinol on FASLG expression in the liver of allopurinol fed
chickens and healthy controls. FASLG mRNA was normalized to that of GAPDH. Female
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males
(n = 3). FASLG expression of treated groups was statistically different from the control groups.
The treatment was found to be significant at a t-Ratio 5.10 and p-value=0.0476. All groups were
found to similar when analyzing with Tukey-HSD.
Figure 4a. The effect of allopurinol on IL-6 expression in the midbrain of allopurinol fed
chickens and healthy controls. IL6 mRNA was normalized to that of GAPDH. Female treated
chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males (n = 3).
The effect of allopurinol on female chickens on IL-6 expression is statistically different from
every other group with an LSM=0.061 and SE=0.031. The effect of allopurinol on male
chickens on IL-6 expression is statistically different from every other group with an LSM=1.98
and SE=0.0312. The control groups of IL-6 expression is statistically different from every other
group with females and males respectively LSM=1.089 and LSM= 1.219 and SE=0.031. The Fratio was 6.392 and p-value=0.016 using an ANOVA test. The combination of sex and treatment
was found to be significant with females at t-Ratio -2.87 and p-value=0.021. Tukey HSD of
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LSM differences show that females with the allopurinol treatment IL-6 expression are
statistically different from every other group. Males were also found to be statistically different
from every other group; while the control groups were statistically different every other group.
Figure 4b. The effect of allopurinol on COX-2 expression in the midbrain of allopurinol fed
chickens and healthy controls. COX-2 mRNA was normalized to that of GAPDH. Female
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males
(n = 3). The effect of allopurinol on COX-2 expression is statistically different from the control
regardless of sex. The treatment was found to be significant at a t-Ratio 2.34 and pvalue=0.0476. All groups were found to similar when analyzing with Tukey-HSD.
iv.

Discussion:

Urate was found to be reduced in all treatment groups regardless of time (p < 0.05)
indicating that the allopurinol treatment generated an inflammatory state [12]. Liver panels were
analyzed to determine if allopurinol could induce toxicity by analyzing major biomarkers.
Treatment groups of both male and females revealed reduced amounts of bile acids throughout
the study (p < 0.05), which suggest an inflammation state in both the intestinal tract and liver [7].
Lower concentrations of bile acids reduce cholesterol solubility, which leads to microcrystal
formation and subsequently the formation of gallstones [7]. Female treated groups exhibited
increased amounts of LDH and AST over time (p < 0.05). The high levels of LDH in the
females suggests some form of tissue damage, which could develop into severe disease over
time. In addition, the high AST levels also serves as a sign of liver damage and immune system
dysfunction [19], [20]. It is also important to note that albumin and globulin ratios were not
altered which indicates that kidney and liver condition is still viable and able to function.
Alkaline phosphatase function was not compromised which indicates that the breakdown of

proteins was not altered, and subsequent liver diseases or bone disorder were not prevalent. Heart
condition was not found to induce failure as indicated by creatine kinases. Total protein was not
found to be different which indicates rates of clearance and production were not altered. BUN
was found to be unaltered which indicated the kidneys are functioning well. IN addition,
phosphorus also monitors kidney function but also bone and liver disease. No changes were
found in the preceding.
Intestines
The effect of allopurinol administration on the duodenal section of the small intestine was
evaluated by examining the expression levels of IL-6, IL-8, FASLG, CCL5, OCLN, TJP1 and
TNF-α. Allopurinol treatment increased the expression of IL-6, COX-2, TNF-α in females by
186, 212 and 108-fold respectively. Intestinal epithelial cells (IECs) form a highly organized
cellular system. Analysis of the intestines is important because the system is maintained in a
dynamic steady state by proliferating and differentiating cells [2], [21]. The cells that originate
from the crypts of Lieberkühn have multiple tasks that participate in digestion, absorption, and
protection [21]. All IECs have been shown to actively defend the epithelial surface, and aid in
the recruitment of immune cells by expressing and secreting pro-inflammatory cytokines and
chemokines [7], [21]. The intestinal cross talk uses growth factors, cytokines, chemokines, and
extracellular proteins between IECs and other cell types to maintain homeostasis [2], [7].
Interleukin 6 exerts multiple functions in the body and serves as indicator of intestinal
inflammation with pleiotropic functions including both a pro-inflammatory and a trophic factor
[4], [14], [15], [22]. Within the intestine, IL-6 has been shown to prevent epithelial apoptosis
during prolonged inflammation while inducing intraepithelial lymphocytes to undergo epithelial
proliferation and wound repair at the site of an inflammatory injury [14], [15], [22]. The 186-fold
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increase of IL-6 in the gut is suggestive of significant immune recruitment and trophic functions
of IECs resulting from the initial insult generated from allopurinol administration. Additionally,
a secondary response could occur to combat infection from microbiota in treated females.
Females may have had a greater induced response due to synergism with to egg laying [23]. The
previous study investigated how probiotics and agents that induce gut sustainability and the
strengthen of the gut barrier would increase the capability, quality of the eggs and the overall
health of females. Which could also warrant reproductive studies to determine the toxicology of
allopurinol and how laying cycles alter reproductive hormones concentrations. An overactive
immune system could be working to correct the initial insult and protect the offspring by over
expressing IL-6 for wound recovery, cell proliferation and the introduction of lymphocytes [9],
[7], [15], [22].
COX-2 converts arachidonate to prostaglandin H2 and is constitutively expressed in the
endothelium, kidney, brain and cancers [23]. COX-2 is responsible for the production of
inflammatory prostaglandins and the upregulation associated cell adhesion, resistance to
apoptosis, and tumor angiogenesis [7], [21], [22]. The 212-fold increase of COX-2 in the
intestines is thus suggestive of the upregulation of cell adhesion to prevent the blood barrier from
deteriorating, especially in females in order to ensure reproductive success associated with egg
lay. Lastly, TNF-α is regulator of both the immune response and inflammation. TNF- α is
expressed by macrophages, T-cells and NK cells, which causes both inflammation and
endothelial activation [7], [15], [21], [22]. The 108-fold increase from the intestines suggests
recruitment of the lymphocytes listed above, resulting in inflammation and endothelial activation
in order to remodel the deteriorating regions from the toxic effects of allopurinol [4]. Allopurinol
as a chemical agent is shown to induce gut instability and the weaken of the gut barrier, alter the

quality of the eggs and the overall fitness of females [23]. An overactive immune system is
working to ameliorate these effects by inducing wound recovery. Which could also warrant
reproductive studies to determine the toxicology of allopurinol on how of reproductive hormones
are being alter in laying cycles concentrations [23].
Liver
The effect of allopurinol administration on the liver was evaluated by examining
expression levels of IL-6, FASLG, CCL5, CRP, KRT-18, OCLN, TJP1 and TNF-α. The liver is
the target organ for many toxic chemicals and plays a central role in detoxification and
elimination [17], [19], [24]. However, when chemical or biological compounds overload the
livers’ functional capacity to clear the drug or infection, it begins to fail [14], [20], [24].
Allopurinol treatment decreased TNF-α expression in the liver in both females and males by 3
and 2-fold compared to the respective control groups while FASLG expression decreased 2-fold
in both male and females compared to their respective controls. The Fas receptor/ligand system
is the most important apoptotic initiator in the liver [20]. Dysregulation of this pathway can
contribute to abnormal cell proliferation, cell death and prevent the immune system from
targeting cancer cells [20], [24]. The findings suggest that the treated groups did not have any
decrease in hepatocyte homeostatic and mitogenic activity, which could have led to liver damage
and other associated pathologies. However, the findings are counterintuitive to the results from
the liver panel which suggested that the low levels of bile acids, increased LDH and AST
indicated liver damage. Moreover, the expression of KRT18, a biomarker for cell damage
analogous to CK in heart failure, was also not shown to have any significant changes [24].
Midbrain
The effect of allopurinol administration on the midbrain was evaluated by examining
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expression levels of IL-6, FASLG, CCL5, OCLN, TJP1 and TNF-α. Interleukin-6 plays a critical
role in the pathogenesis of inflammatory disorders and in the physiological homeostasis of neural
tissue [7], [13], [25]. Profound neuropathological changes such as multiple sclerosis, Parkinson's
and Alzheimer's disease are associated with increased IL-6 expression in brain [7], [13], [25].
Allopurinol administration to the egg laying female chickens decreased IL-6 expression
compared to its respective controls to a fold change of 0.061 with the combination of sex and
treatment found to be significant (P <0.05). These data suggest that allopurinol reduced both the
remodeling potential and inflammation state in these birds [26]. However, allopurinol increased
IL-6 expression in adult male chickens compared to their respective controls by 1.98 times with
the combination of sex and treatment found to be significant (P<0.05), which suggests that males
were more suspectable to developing inflammation when comparing both treatment groups [26].
The upregulation in IL-6 expression suggests the use of male treated chickens to investigate
other neuropathological disorders [7]. However, additional experiments need to be conducted to
determine if other inflammatory pathways are also being upregulated could mimic conditions
such as multiple sclerosis, Parkinson's and Alzheimer's disease.
COX-2 is an inducible and rapidly expressed gene that responds to growth factors,
cytokines, and pro-inflammatory molecules [27], [28]. Since its discovery, COX-2 has been
recognized as a major contributor to inflammatory reactions in peripheral tissues that can
progress to several acute and chronic diseases [7], [27], [28]. However, in the central nervous
system, COX-2 is expressed under normal conditions and contributes to fundamental brain
functions, such as synaptic activity, memory consolidation, and functional hyperemia [27], [29].
The gene is thus tightly regulated, as it is triggered and sustained by the activation of microglia
[27], [29]. Allopurinol increased COX-2 expression in the midbrain both females and males by 7

and 10-fold respectively, which suggests that that both treated groups are involved in extensive
neuroinflammation and remodeling due low urate levels [29].
v.

Conclusion:

The reduced levels of urate in avians that have been traditionally linked to oxidative
stress, now purport investigations on the mechanisms by which urate interacts with systemic
organs. Results from the present study suggest that the inflammatory pathways in the intestines
of female’s chickens respond more intensely to allopurinol administration than males.
Interestingly, allopurinol treatment results in an increase in intestinal permeability due to insult
from the drug, which increases the expression of IL-6. Moreover, expression levels of IL-6 in the
brain of males suggest that inflammation was induced in the midbrain. The function of
neurological remodeling and inflammation associated with it to be increased in both sexes with
the upregulation of COX-2 occurring in both sexes. Allopurinol was suggested to induce cellular
remodeling of the intestines and generate an inflammation state in due to the upregulation of IL6, COX-2 and TNF-α. Which could also warrant reproductive studies to determine the
toxicology of allopurinol on how of reproductive hormones are being alter in laying cycles
concentrations. Results from the liver panel also suggested an inflammatory state as reduced
amounts of bile acids and urate and increased amounts of LDH and AST were measured in
females. However, TNF-α and FASLG expression in the liver were decreased in both females
and males, which indicates that the inflammation may not have been severe. The midbrain of
allopurinol treated females revealed that IL-6 expression decreased, which suggests that
allopurinol reduces the inflammatory potential in the brain tissue of female chickens. However,
an upregulation in males could indicate that allopurinol induces an increase in IL-6 which could
be used to create a model of neuropathological disorders. The increased expression COX-2 also
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bolsters the idea that neuromodulation is upregulated due to treatment. Additional experiments
must be conducted in males to determine if other inflammatory pathways are being upregulated
that could possibly mimic the conditions associated with the development of multiple sclerosis,
Parkinson's and Alzheimer's disease.
Future experiments should involve a redesign of the experiment model by four separate
groups: control males, control females, treated males and treated females each with their own
feed to strengthen the power of these findings. Another facet that could be improved upon is
preforming weekly or biweekly bleeds of all chickens as well as collection of tissues. With these
bleeds, additional biomarkers could be measured with liver panels and evaluating genes that are
involved with liver toxicity, inflammation and regulatory pathways. Additional proinflammatory
proteins that should be investigated include IL-1B, IL-11 and IL-8, whereas regulatory pathways
can be further characterized by investigating IL-4, IL-6, IL-10, IL-11, and IL-13. In addition to
evaluating mRNA expression levels of these biomarkers, protein levels could be investigated
with ELISAs. Lastly, additional biomarkers associated with neurological disorders should be
measured to determine the effect of low urate on neurological inflammation.
vi.
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Figure 2a. Relative expression levels of IL-6 in the intestines.
The effect of allopurinol on female chickens for IL-6 expression is statistically
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increased from every other group by 185.93 times.
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Figure 2b. Relative expression levels of COX-2 in the intestines.

The effect of allopurinol on female chickens for COX-2 expression is statistically
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increased from every other group by 211.74 times.
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Figure 2c. Relative expression levels of TNF-α in the intestines.
The effect of allopurinol on female chickens for TNF-α expression is statistically
increased from every other group by 107.52 times.
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Figure 3a. Relative expression levels of TNF-α in the liver.
The effect of allopurinol on TNF-α expression has statistically decreased in both
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Figure 3b. Relative expression levels of FASLG in the liver.

The effect of allopurinol on FASLG expression has statistically decreased by 2 times
in both male and females from the control group respectively.
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Figure 4a. Relative expression levels of IL-6 in the midbrain. The effect of
allopurinol on female chickens on IL-6 expression has statistically decreased from its
respective control with an LSM=0.061 and SE=0.0312. The effect of allopurinol on male
chickens on IL-6 expression has statistically increased from its respective control group
LSM=1.98 and SE=0.0312.
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Figure 4b. Relative expression levels of COX-2 in the midbrain.
The effect of allopurinol on COX-2 expression has statistically increased in females
and males by 7 and 10 times from the control group respectively.

